[Highlight] Why Dog Longevity Drugs Are the Fastest Path to Human Longevity with Celine Halioua

Impossible d'ajouter des articles

Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.

Veuillez réessayer plus tard

Échec de l’élimination de la liste d'envies.

Veuillez réessayer plus tard

Impossible de suivre le podcast

Impossible de ne plus suivre le podcast

[Highlight] Why Dog Longevity Drugs Are the Fastest Path to Human Longevity with Celine Halioua

Écouter gratuitement

Voir les détails

À propos de ce contenu audio

This is a short excerpt from our full conversation with Celine Halioua, Founder & CEO of Loyal, which recently raised a $100M Series C, and Village Global GP Sam Kirschner.

Celine discusses Loyal's 10-year vision for expanding into cats and humans, why the pharmaceutical industry has been slow to treat aging as a drug category, and why the biological and economic case for going dogs-first is stronger than most people realize.

Listen to the full episode here: https://www.villageglobal.com/podcast

Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at www.villageglobal.com or get in touch with us on X @villageglobal.

Want to get updates from us? Subscribe to get a peek inside the Village. We'll send you reading recommendations, exclusive event invites, and commentary on the latest happenings in Silicon Valley. www.villageglobal.com/signup

Aucun commentaire pour le moment